Pharmacogenomics

(ISSN: 1462-2416, 1744-8042)

Mission Statement

Pharmacogenomics is a peer-reviewed journal presenting reviews, original research and reports by the scientists, clinicians and decision-makers who are most closely involved in this rapidly developing area. The journal is the leading source of commentary and analysis in this evolving field, presenting the expert analyses from key opinion leaders.

Coverage includes:

  • Emergence of new pharmacogenomic initiatives and their impact on research and medical practice
  • Regulatory issues
  • Emerging technologies for accessing and exploiting genomic information
  • Linkage of genotyping and clinical data in specific therapeutic areas
  • Development of novel diagnostic products and strategies

Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.

The journal welcomes unsolicited article proposals.

Contact Information

http://www.futuremedicine.com/feedback/show

Subscription Information

http://www.futuremedicine.com/page/subscribe.jsp

Reprints & Supplements

http://www.futuremedicine.com/page/reprints.jsp

Editorial Advisory Board

http://www.futuremedicine.com/page/journal/pgs/editors.jsp

Indexing Information

http://www.futuremedicine.com/page/indexing

Author Guidelines

http://www.futuremedicine.com/page/authors.jsp

Journal Information